Pharmaceuticals
October 2020
Takeda: The governance of strategic transformation (B) (Japanese)
By Harry Korine, Kazuhiro Asakawa
The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to…
October 2020
Takeda: The Governance of Strategic Transformation (A) (Japanese)
By Harry Korine, Kazuhiro Asakawa
The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to…
September 2018
David Pyott: The Battle for Allergan (B)
By Randall Peterson, Lisa Duke
This case series charts the evolution of the hostile battle for Allergan and its ultimate sale to a white knight, Actavis. David Pyott had been the CEO of Allergan since January 1998; only the third…
November 2018
Takeda: The governance of strategic transformation (B)
By Harry Korine, Kazuhiro Asakawa
The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to…
November 2018
Takeda: The governance of strategic transformation (A)
By Harry Korine, Kazuhiro Asakawa
The case series describes strategic transformation at Takeda, the largest Japanese pharmaceutical company, with a special focus on the R&D function. Since 2015, the 237-year-old industry doyen has narrowed its strategic focus from six to…